Apollomics Inc (NASDAQ:APLM) has a beta value of 1.25 and has seen 137.79 million shares traded in the recent trading session. The company, currently valued at $19.46M, closed the recent trade at $0.18 per share which meant it gained $0.02 on the day or 13.14% during that session. The APLM stock price is -2927.78% off its 52-week high price of $5.45 and 27.78% above the 52-week low of $0.13. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.51 million shares traded. The 3-month trading volume is 1.13 million shares.
The consensus among analysts is that Apollomics Inc (APLM) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Apollomics Inc (NASDAQ:APLM) trade information
Sporting 13.14% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the APLM stock price touched $0.18 or saw a rise of 36.64%. Year-to-date, Apollomics Inc shares have moved -81.44%, while the 5-day performance has seen it change 19.32%. Over the past 30 days, the shares of Apollomics Inc (NASDAQ:APLM) have changed -9.77%. Short interest in the company has seen 0.39 million shares shorted with days to cover at 0.18.
Apollomics Inc (APLM) estimates and forecasts
Figures show that Apollomics Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -74.41% over the past 6 months, with this year growth rate of 71.98%, compared to 17.10% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -98.15% over the past 5 years.
APLM Dividends
Apollomics Inc is expected to release its next earnings report 2024-Mar-28 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Apollomics Inc (NASDAQ:APLM)’s Major holders
Insiders own 48.02% of the company shares, while shares held by institutions stand at 9.25% with a share float percentage of 17.79%. Investors are also buoyed by the number of investors in a company, with Apollomics Inc having a total of 16.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are ETF Series Solutions-Range Cancer Therapeutics ETF and Fidelity NASDAQ Composite Index Fund. As of May 31, 2024, the former fund manager holds about 0.35% shares in the company for having 384.18 shares of worth $69537.0 while later fund manager owns 57.22 shares of worth $10357.0 as of Jun 30, 2024, which makes it owner of about 0.05% of company’s outstanding stock.
